CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This study is an adaptive, randomized, open-label, controlled clinical trial, in collaboration with countries around the world through the World Heal...
Phase 3
Montréal, Quebec, Canada and 52 other locations
COVID-19 patients who develop severe disease often develop acute respiratory distress syndrome (ARDS) as a result of a dysregulated...
Phase 2, Phase 3
Montréal, Quebec, Canada and 19 other locations
A randomized, double-blind, placebo-controlled Phase 2/3 Study of LAU-7b against confirmed COVID-19 Disease in hospitalized patient...
Phase 2, Phase 3
Montréal, Quebec, Canada and 28 other locations
The purpose of this study is to evaluate the safety, reactogenicity, and relative vaccine efficacy (rVE) of the mRNA-1283.222 vaccine as well as its...
Phase 3
Pointe-Claire, Quebec, Canada and 217 other locations
The purpose of this study is to find out if immunization with IMM-101 will reduce the incidence of severe respiratory and COVID-19 ...
Phase 3
Montreal, Quebec, Canada and 7 other locations
known SARS-CoV-2 variants of concern for pre-exposure prophylaxis of COVID-19.The aim of the Phase I/III study (Parent Study) will -...
Phase 2, Phase 3
Montreal, Quebec, Canada and 214 other locations
proteins of three coronaviruses: SARS-CoV-2 (the virus that causes COVID-19 disease), SARS-CoV-1 and MERS-CoV. The trivalent vaccin...
Phase 1
Pointe-Claire, Quebec, Canada and 6 other locations
The main goals of this study are to assess the immune response and safety of two different vaccines for first, second, third and fourth doses as well...
Phase 2
Montréal, Quebec, Canada and 7 other locations
This Phase 2/3 study is a multi-portion design to confirm that the chosen formulation and dosing regimen of CoVLP has an acceptable immunogenicity an...
Phase 2, Phase 3
Pierrefonds, Quebec, Canada and 90 other locations
ESSOR is a double-blind, placebo-controlled study of the orally-administered antiviral and inflammation-controlling LAU-7b for the treatment of adult...
Phase 2, Phase 3
Montréal, Quebec, Canada and 4 other locations
Clinical trials
Research sites
Resources
Legal